NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled
NCT00369564 2021-08-11Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With CancerUniversity of South FloridaPhase 3 Completed250 enrolled 10 charts
NCT00365768 2016-09-09Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsColumbia UniversityPhase 2 Completed56 enrolled 5 charts